About the Authors

Paul Garner

pgarner@liv.ac.uk

Affiliation Liverpool School of Tropical Medicine, Liverpool, United Kingdom

Competing Interests

The author is Director of Evidence Building and Synthesis Research Consortium, which receives money to increase the number of evidence-informed decisions by intermediary organizations, including WHO and national decision makers that benefit the poor in middle- and low-income countries. The author is the coordinator of a WHO Collaborating Centre for Evidence Synthesis for Infectious and Tropical Diseases (http://apps.who.int/whocc/default.aspx; UNK234). One of the Centre's aims is to help WHO in its role as an infomediary in communicating reliable summaries of research evidence to policymakers, clinicians, teachers, and the public in developing countries. Technical advice was sought from Dr. Dianne J. Terlouw on the pharmacokinetic background to these drugs. Dr. Terlouw is the Principal Investigator on a trial examining dose optimisation with DHAP. Dr. Terlouw had no part in writing the manuscript and the views expressed are entirely those of the author.

Author Contributions

Wrote the first draft of the manuscript: PG. Contributed to the writing of the manuscript: PG. ICMJE criteria for authorship read and met: PG. Agree with manuscript results and conclusions: PG.